BeiGene’s Post

2023 has been stand out year for us at Cerca Biotech. We doubled our team, added a major partner in Sysmex Europe, and we were present at all the major #BreastCancer congresses. Find out more about what else we have done this year to move breast cancer diagnostics forwards, in our latest update: link in the comments. #Biotech #HealthInnovation #CancerDiagnostics

In the world of #oncology research, innovation is the compass which guides us toward new horizons. We are focusing our efforts on synergistic approaches targeting key pathways designed to hit #cancer at its core. Learn more about how our approach in oncogenic signaling may help transform the future of cancer care. https://bit.ly/3M7lFUG #ScienceOfCancer #ESMO23 #HCPsOnly

In Australia, about 1 in 7 women is likely to face breast cancer, making regular screening with advanced digital tools essential. Visit us at Booth 10 during The BreastScreening Australia Conference in Canberra (March 13-15) to explore how our BreastScreen Information System (BIS) transforms breast cancer screening, enhances early detection, and elevates the patient experience. #earlydetection #digitalhealth #BreastCancerAwareness

We know plans struggle with getting their members to complete screening tests. This webinar addresses different ways to capture compliance, increasing STARS ratings and improving patient outcomes.

Please find below a link to Sona Nanotech’s recent investor webinar, which provides a detailed discussion of the first phase of interim results from our current pre-clinical efficacy study of Sona's innovative cancer treatment technology, that may better enable standard cancer immunotherapies. Watch the full webinar replay here: https://bit.ly/3UqsKo1 #oncologyresearch #cancerresearch #medicalindustry #thermalhyperthermiatherapy #boweldiseases #cancerresearchuk #stockmarketnews #Cancer #medicaltechnology #medical #interventionaloncology #biosimilars #clinicaltrials

🔬ER-positive female breast cancer survivors worldwide are needed for an online study! Help researchers learn why some women have their breast cancer come back. If you participate in this study, you will be asked to complete six online questionnaires over five years. Sign up at the link in our bio. #LoveRA #LoveResearchArmy #Participate #Study

Connect with colleagues, collaborators, and fellow advocates at the #cancerconference in #spain. Build meaningful relationships, exchange ideas, and foster collaborations that can drive progress in #cancer research and care. Register here: https://lnkd.in/gZUY4HEw #cancerconference #cancercare #joinus #registernow #oncology

How do you make the decision to end or extend your HR+, early-stage breast cancer patients’ endocrine therapy after their first initial 5 years? Let Breast Cancer Index help take the guess work out of your decision. Nice talk by Drs. Rena Callahan and VK Gadi.

Connect with colleagues, collaborators, and fellow advocates at the #cancerconference in #spain. Build meaningful relationships, exchange ideas, and foster collaborations that can drive progress in #cancer research and care. Register here: https://lnkd.in/dupRwKGD #cancerconference #cancercare #joinus #registernow #oncology

Watch Drs. Rena Callahan*, UCLA Health, and VK Gadi*, University of Illinios Cancer Center, discuss evolving trends in HR+, early-stage breast cancer diagnostics. Listen to them present the data on the Breast Cancer Index® test and discuss utilization of the test in clinical case studies. https://lnkd.in/g6TqSr3E